Indaptus Therapeutics Inc. INDP
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Indaptus Therapeutics Inc. is a clinical-stage biotechnology company focused on developing systemically administered immunotherapies for cancer and chronic viral infections. The company’s core platform leverages proprietary, attenuated, killed, non-pathogenic Gram-negative bacteria engineered to reduce intravenous toxi…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees5
TickerINDP
Statistics
Market Cap$557.2M
Revenue (TTM)$0
Net Income-$20.8M
Net Margin—
EPS$-21.58
P/E-0.15
P/S—
P/B324.55
EV/EBITDA-20.31
ROE-931.8%
Dividend Yield—
Price$4.92
Data: Twelve Data · Revenue = mcap / P/S